...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis, in vitro antitumor activity, dihydrofolate reductase inhibition, DNA intercalation and structure-activity relationship studies of 1,3,5-triazine analogues
【24h】

Synthesis, in vitro antitumor activity, dihydrofolate reductase inhibition, DNA intercalation and structure-activity relationship studies of 1,3,5-triazine analogues

机译:1,3,5-三嗪类似物的合成,体外抗肿瘤活性,二氢叶酸还原酶抑制,DNA嵌入和构效关系研究

获取原文
获取原文并翻译 | 示例
           

摘要

A series of triazine-benzimidazoles with 4-fluoroaniline substitution has been designed and synthesized. These compounds were further substituted with different primary and secondary amines. The structures of newly synthesized compounds were confirmed by H-1, C-13 NMR, mass spectrometry and, in case of compound 18, by single crystal X-ray diffraction analysis. The newly synthesized compounds were evaluated against 60 human tumor cell lines at one dose and five dose concentration levels. Compounds 7, 8 and 22 have been found to be the most active antitumor agents with GI(50) values of 1.77, 1.94 and 2.87 mu M, respectively. The synthesized compounds were then evaluated for their inhibitory activity to mammalian dihydrofolate reductase. Compound 22 was depicted as the most active compound for the inhibition of dihydrofolate reductase with IC50 value of 2.0 nM. DNA binding studies were also revealed strong interacting properties of triazine derivatives towards calf thymus-DNA. (C) 2015 Elsevier Ltd. All rights reserved.
机译:设计并合成了一系列被4-氟苯胺取代的三嗪-苯并咪唑。这些化合物进一步被不同的伯胺和仲胺取代。新合成的化合物的结构通过H-1,C-13 NMR,质谱确定,对于化合物18,通过单晶X射线衍射分析确定。以一剂和五剂浓度水平针对60种人类肿瘤细胞系评估了新合成的化合物。已发现化合物7、8和22是最有活性的抗肿瘤药,其GI(50)值分别为1.77、1.94和2.87μM。然后评估合成的化合物对哺乳动物二氢叶酸还原酶的抑制活性。化合物22被描述为抑制二氢叶酸还原酶的最具活性的化合物,IC50值为2.0 nM。 DNA结合研究还揭示了三嗪衍生物与小牛胸腺DNA的强相互作用特性。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号